A major new study reveals that both sugar-sweetened beverages (SSBs) and low- or non-sugar-sweetened beverages (LNSSBs) are significantly associated with a higher risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD).| EurekAlert!
PepsiCo spent $1.65 billion to buy out its soda competitor, poppi. The move comes as Americans are drinking less soda nearly every year.| Straight Arrow News
A new study out of Brazil found that six popular artificial sweeteners could be linked to decreased cognitive function and verbal fluency.| Straight Arrow News
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common disease that happens when fat builds up in your liver. Having obesity and Type 2 diabetes increases your risk of MASLD. Learn more here.| Cleveland Clinic
